Form D · Other Health Care
Fresenius Medical Care New Lenox, LLC
Waltham, MA · CIK 0001813807
Offering snapshot reported Jun 3, 2020 · SEC filing
- Reported sold
- $2.38M Offering amount: $2.38M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1.17M Reported outside-investor minimum
- First sale
- May 26, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 3, 2020 | Initial | $2,383,249 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-368180
Source: Form D, filed Jun 3, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Morufu Olatunji Alausa | Director |
| Teri Gurchiek | Director |
| Lailane Parinas | Director |
| Mohammad Shafi | Director |
| Ryan M. Valle | Director |
| Marybeth Wiekierak | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Fresenius Medical Care North America 920 Winter Street
Waltham, MA, 28246
Waltham, MA, 28246